Press releases

GPR153 promotes inflammatory reactions in the vessel wall in response to acute damage more

RBPMS and RBPMS2 regulate cell division and function during heart development more

A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD). more

Foundation of the former German President and his wife honours innovative therapeutic approach for Duchenne muscular dystrophy more

Max Planck Institute again successful together with Universities of Giessen and Frankfurt in Federal Excellence Initiative more

On Sunday, March 30, 2025, the clocks in Germany will spring forward for daylight saving time. While we all adjust our watches, phones, and computers, what does this shift really do to our bodies? Experts from three different Max Planck Institutes shed light on this question. more

GPRC5B influences the Prostaglandin Receptor and affects the immune response more

Utrophin increase in muscle cells via transcriptional adaptation normalises cell function in Duchenne muscular dystrophy more

The hormone triggers insulin resistance in blood vessel endothelium in obesity more

An enzyme called Ubiquitin-specific peptidase 5 is a key factor in protein quality in heart muscle cells. more